156 related articles for article (PubMed ID: 29883024)
1. Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity.
Leung LLK; Morser J
J Thromb Haemost; 2018 Jun; ():. PubMed ID: 29883024
[TBL] [Abstract][Full Text] [Related]
2. Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice.
Morser J; Shao Z; Nishimura T; Zhou Q; Zhao L; Higgins J; Leung LLK
J Thromb Haemost; 2018 May; 16(5):991-1002. PubMed ID: 29383821
[TBL] [Abstract][Full Text] [Related]
3. Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice.
Zhou Q; Zhao L; Shao Z; Declerck P; Leung LLK; Morser J
J Thromb Haemost; 2022 Jan; 20(1):238-244. PubMed ID: 34626062
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin.
Tawara S; Sakai T; Matsuzaki O
Thromb Res; 2016 Nov; 147():72-79. PubMed ID: 27693845
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
Campbell WD; Lazoura E; Okada N; Okada H
Microbiol Immunol; 2002; 46(2):131-4. PubMed ID: 11939578
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.
Mueller-Ortiz SL; Wang D; Morales JE; Li L; Chang JY; Wetsel RA
J Immunol; 2009 May; 182(10):6533-9. PubMed ID: 19414808
[TBL] [Abstract][Full Text] [Related]
8. Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis.
Campbell W; Okada N; Okada H
Immunol Rev; 2001 Apr; 180():162-7. PubMed ID: 11414358
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL; Myles T; Nishimura T; Song JJ; Robinson WH
Mol Immunol; 2008 Oct; 45(16):4080-3. PubMed ID: 18706698
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL; Nishimura T; Myles T
Adv Exp Med Biol; 2008; 632():61-9. PubMed ID: 19025114
[TBL] [Abstract][Full Text] [Related]
11. Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
Leenaerts D; Aernouts J; Van Der Veken P; Sim Y; Lambeir AM; Hendriks D
Thromb Haemost; 2017 Jul; 117(8):1498-1508. PubMed ID: 28692110
[TBL] [Abstract][Full Text] [Related]
12. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?
Claesen K; Mertens JC; Leenaerts D; Hendriks D
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477318
[TBL] [Abstract][Full Text] [Related]
13. Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
Hu X; Wetsel RA; Ramos TN; Mueller-Ortiz SL; Schoeb TR; Barnum SR
Immunobiology; 2014 Feb; 219(2):104-8. PubMed ID: 24028840
[TBL] [Abstract][Full Text] [Related]
14. Elastase from activated human neutrophils activates procarboxypeptidase R.
Kawamura T; Okada N; Okada H
Microbiol Immunol; 2002; 46(3):225-30. PubMed ID: 12008933
[TBL] [Abstract][Full Text] [Related]
15. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not.
Sato T; Miwa T; Akatsu H; Matsukawa N; Obata K; Okada N; Campbell W; Okada H
J Immunol; 2000 Jul; 165(2):1053-8. PubMed ID: 10878383
[TBL] [Abstract][Full Text] [Related]
16. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
[TBL] [Abstract][Full Text] [Related]
17. Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior.
Meijers JCM; van der Harst J; Marx PF; Sahbaie P; Clark DJ; Morser J
Thromb Haemost; 2024 Jan; 124(1):4-19. PubMed ID: 37532120
[TBL] [Abstract][Full Text] [Related]
18. Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice.
Asai S; Sato T; Tada T; Miyamoto T; Kimbara N; Motoyama N; Okada H; Okada N
J Immunol; 2004 Oct; 173(7):4669-74. PubMed ID: 15383602
[TBL] [Abstract][Full Text] [Related]
19. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity.
Walker JB; Binette TM; Mackova M; Lambkin GR; Mitchell L; Bajzar L
J Thromb Haemost; 2008 May; 6(5):848-55. PubMed ID: 18221361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]